Strategic & Corporate Investors

It can bring distribution, technology, credibility and market access alongside capital.

Often yes; we structure terms that protect your optionality.

Strategic investors value a business on what it is worth to them — including synergies, market access and technology — rather than on stand-alone financial returns alone. This can support a higher price than purely financial investors will offer, but it also ties value to the commercial relationship that follows.

The main risks of strategic investment are loss of optionality and information leakage: a corporate shareholder may deter rival partners or acquirers, and gains insight into your business. These risks are managed through carefully negotiated information rights, non-compete boundaries and provisions that preserve a competitive future sale process.

Before accepting a corporate investor, negotiate the scope of information rights, board representation, any commercial agreements attached to the investment, rights of first refusal and what happens on exit. The aim is to capture the commercial upside of the partnership without ceding control of your strategic options or eventual sale.

Matchpoint prepares your equity story and investor materials, maps your raise against a curated base of PE funds, family offices, SWFs, VCs and strategic investors, and runs the process to close. Typical equity tickets range from USD 5m to USD 300m.

Assess the adviser against the transaction size, sector and geography; the quality of its investor-screening method; senior involvement; preparation capability; conflicts; process reporting; fee transparency; and its ability to support diligence and term-sheet comparison. Ask to see the proposed deliverables and qualification fields before any outreach begins.

The target list should record each investor's sector, stage, geography, cheque size, preferred instrument, governance requirements, relevant portfolio or transaction evidence, conflicts, relationship route and the reason the investor fits the mandate. It should be prioritised and updated as feedback is received.

Venture capital funds early-stage, high-growth companies (seed to Series C) for minority equity, while private equity backs more established businesses via growth equity, buy-outs or minority stakes. We raise both, matching the investor to your stage and sector.

Yes. We support founders from MVP traction through growth rounds — building the pitch, model and go-to-market narrative, then introducing the company to seed and growth-stage investors across MENA and India.

Engagements ordinarily combine a retainer with a success fee. Terms are agreed in writing before work begins and calibrated to the mandate’s size, scope and complexity.

Most mandates reach a first term sheet within 30 days, depending on diligence readiness and structure; closing follows once terms are agreed.

A short, confidential scoping call and NDA; we structure the requirement and prepare materials, then run a competitive process across our 5,000+ investor and lender relationships, and negotiate to close — with a partner leading at every step.

Matchpoint Partners is based in the UAE and runs cross-border mandates across the UAE, KSA, India and the UK, with active deal activity in wider Europe, Singapore and the United States.

Matchpoint undertakes corporate finance, financing, M&A and fund-placement mandates from USD 5m upwards, subject to mandate fit, diligence, applicable regulation, capacity and a written engagement. The partner team has originated and led $2+ billion of transactions.

Use the enquiry form, email contact@matchpoint-partners.com, or call/WhatsApp +971 52 345 1119. Every mandate is led by a partner from the very first conversation.

Yes. Confidential information is handled under the engagement terms and any applicable non-disclosure agreement.